Roquette Announces a New Organizafion following the Acquisifion of IFF Pharma Solufions

PRESS RELEASE

Roquefte Completes the Acquisifion of IFF Pharma Solufions

Lille, May 1, 2025 – Roquefte, a global leader in plant-based ingredients and pharmaceufical excipients for the health and nutrifion sectors, announces the successful complefion of its acquisifion of IFF Pharma Solufions. This strategic milestone marks a significant step forward in its ambifion to become a leader in support of the global pharma markets.

With this acquisifion, and following that of Qualicaps in 2023, Roquefte decisively strengthens its posifion as a key player in the health industry by integrafing IFF Pharma Solufions’ experfise and innovafive product porffolio. The transacfion enhances Roquefte’s ability to deliver high-value drug delivery solufions to pharmaceufical customers worldwide while reinforcing its commitment to innovafion. The acquisifion aligns perfectly with Roquefte’s long-term strategy of invesfing in highgrowth markets across the globe and providing cufting-edge solufions that meet evolving industry needs. 

Pierre Courduroux, CEO of Roquefte, commented: “The successful acquisifion of IFF Pharma Solufions marks a major step forward in our value-creafion journey. We are thrilled to officially welcome our new colleagues as we start to write the next chapter of Roquefte's history. This pivotal move aligns perfectly with our strategic vision to provide innovafive, high-quality excipients that improve the efficacy and safety of pharmaceufical formulafions. By combining our strengths, Roquefte is poised to become the pharmaceufical industry’s go-to partner for the development of drug delivery solufions that contribute to improving, sustaining, and saving pafients’ lives.”

Roquefte – Offering the best of nature

Roquefte is a family-owned global leader in plant-based ingredients and a leading provider of pharmaceufical excipients. Founded in 1933, the company currently operates in more than 150 countries, through more than 40 manufacturing sites, with a turnover of €4.5 billion in 2024, and employs more than 11,000 people worldwide.

Life and nature have been our sources of inspirafion for decades. All our raw materials are of natural origin. From them, we enable a whole new plant-based cuisine; we offer pharmaceufical solufions that play a key role in medical treatments; and we develop innovafive ingredients for the food, nutrifion and health markets. We truly unlock the potenfial of nature to improve, cure and save lives.

Thanks to a constant drive for innovafion and a long-term vision, we are commifted to improving the well-being of people all over the world. We put sustainable development at the heart of our concerns, while taking care of resources and territories. We are determined to create a befter and healthier future for all generafions.

Discover more about Roquefte at this link.

PRESS RELEASE

Press Contacts:

Brunswick:

Aurélia de Lapeyrouse +33 (0) 6 21 06 40 33 adelapeyrouse@brunswickgroup.com

Roquefte:

Corporate Communicafions:

Susannah Duquesne

+33 (0) 6 64 42 40 98

Susannah.duquesne@roquefte.com